Virtu Financial’s Autolus Therapeutics AUTL Stock Holding History

Virtu Financial’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38K	Buy	+23,557	New	+$37K	﹤0.01%	1264
2023 Q4	–	Sell	-13,880	Closed	-$32K	–	1557
2023 Q3	$32K	Buy	+13,880	New	+$39.5K	﹤0.01%	952
2022 Q1	–	Sell	-16,871	Closed	-$88K	–	1485
2021 Q4	$88K	Buy	+16,871	New	+$101K	0.01%	1177
2021 Q3	–	Sell	-129,907	Closed	-$863K	–	1493
2021 Q2	$863K	Buy	+129,907	New	+$806K	0.08%	251

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial's AUTL Position: Q2 2026 in Review

Virtu Financial opened a new position in Autolus Therapeutics (AUTL) in Q2 2026: 23,557 shares worth $38K. The stake represents ﹤0.01% of the portfolio and ranks #1264 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AUTL as recently as Q3 2023.

Virtu Financial first reported a position in AUTL in Q2 2021 and has held it in 4 quarters since. The position peaked at $863K in Q2 2021. 83 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

Virtu Financial held 23,557 shares of Autolus Therapeutics worth $38K as of Q2 2026.
Autolus Therapeutics was a new Virtu Financial position in Q2 2026.
Autolus Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1264 holding.
Virtu Financial first reported a position in Autolus Therapeutics in Q2 2021 and has held it in 4 quarters since.
Virtu Financial's Autolus Therapeutics position peaked at $863K in Q2 2021.
83 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.